Read + Share
. Retraction: "Safety and immunogenicity of a recombinant receptor-binding
domain-based protein subunit vaccine (Noora vaccine) against COVID-19 in adults:
A randomized, double-blind, placebo-controlled, Phase 1 trial". J Med Virol 2024;96:e29509.
PMID: 38430205
|
 |
|
